Preparation of the dialysis patient with type 1 diabetes mellitus for kidney transplantation

Kidney transplantation is unique method of renal replacement therapy, allowing to improve quality and duration of life for patients with diabetes mellitus type 1 (DM1) and end-stage renal disease (ESRD) on dialysis therapy. Recently using of innovation technologies for diabetes management and modern immunosuppression enable achieving better results of posttransplant rehabilitation for patients with DM1, especially if kidney transplantation is performed early after initiation of dialysis. Detailed examination of patient with DM1 before potential kidney transplantation is very important to reduce of early and late postoperative complications. Kidney transplantation preparation includes effective glycemic control, adequate dialysis therapy, treatment of diabetes and ESRD complications and concomitant conditions, especially cardiovascular diseases, accounting for kidney transplantation perspective. Furthermore, diagnostics and treatment of any infectious process, timely vaccination, cancer screening are basic approaches of kidney transplantation preparation program, providing the best survival rate of kidney graft and patient.

1. International Diabetes Federation. IDF Diabetes atlas. 9th edition. 2019. 168 p. ISBN: 978-2-930229-87-4

2. You W-P, Henneberg M. Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabetes Res Care. 2016;4(1):e000161. doi: https://doi.org/10.1136/bmjdrc-2015-000161

3. Xu G, Liu B, Sun Y, et al. Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study. BMJ. 2018:k1497. doi: https://doi.org/10.1136/bmj.k1497

4. Dedov II, Shestakova MV, Vikulova O.K., et al. Atlas of Diabetes Register in Russian Federation, status 2018. Diabetes mellitus. 2019;22(2S):4-61. (In Russ.). doi: https://doi.org/10.14341/DM12208

5. Dedov II, Shestakova MV, Vikulova OK. Epidemiology of diabetes mellitus in the Russian Federation: clinical and statistical report for 2016 according to the federal diabetes registry. Diabetes mellitus. 2017;10(1):13-41. (In Russ.). doi: https://doi.org/10.14341/DM20171

6. Helve J, Sund R, Arffman M, et al. Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes. Diabetes Care. 2018;41(3):434-439. doi: https://doi.org/10.2337/dc17-2364

7. Gheith O, Othman N, Nampoory N, et al. Diabetic kidney disease: difference in the prevalence and risk factors worldwide. J Egypt Soc Nephrol Transplant. 2016;16(3):65. doi: https://doi.org/10.4103/1110-9165.197379

8. Bakris GL, Molitch M. Are All Patients With Type 1 Diabetes Destined for Dialysis if They Live Long Enough? Probably Not. Diabetes Care. 2018;41(3):389-390. doi: https://doi.org/10.2337/dci17-0047

9. Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-733. doi: https://doi.org/10.1016/S0140-6736(20)30045-3

10. US Renal Data System 2019 Annual Data Report. Epidemiology of kidney disease in the United States. Available from: https://www.usrds.org/media/2371/2019-executive-summary.pdf

11. Российское диализное общество [интернет]. Доступно по ссылке: http://nephro.ru/index.php?r=site/pageView&id=298%20,%20journal.nephro.ru/index.php?r=journal/pageView&id=298

12. Bikbov BT, Tomilina NA. The contingent and treatment quality indicators in patients on replacement therapy of end stage renal disease in the russian federation in 1998-2013 years. Nephrology and dialysis. 2016;18(2):98-164 (In Russ.).

13. Ortiz F, Harjutsalo V, Helanterä I, Lempinen M, Forsblom C, Groop P-H. Long-term Mortality After Kidney Transplantation in a Nationwide Cohort of Patients With Type 1 Diabetes in Finland. Diabetes Care. 2019;42(1):55-61. doi: https://doi.org/10.2337/dc18-1029

14. Subramaniam K., Sakai T. Anesthesia and perioperative care for organ transplantation. New York: Springer Science+Business Media; 2017.

15. Shumakov VI, Moisyuk YaG, Tomilina NA. V kn. Nefrologiya. Transplantatsiya pochki. Rukovodstvo dlya vrachei / Pod red. I.E. Tareevoi. M.: Meditsina; 2000. 688 c. (In Russ.).

16. Vademecum. Деловой журнал об индустрии здравоохранения [интернет]. Доступно по ссылке: https://vademec.ru/news/2020/03/19/kolichestvo-transplantatsiy-organov-v-2019-vyroslo-na-11/. Ссылка активна 23.09.2020.

17. Arzumanov SV. Rol’ transplantatsii podzheludochnoy zhelezy v lechenii terminal’noy stadii diabeticheskoy nefropatii. [dissertation] Moskva; 2018. (In Russ.)/ Доступно по: https://www.dissercat.com/content/rol-transplantatsii-podzheludochnoi-zhelezy-v-lechenii-terminalnoi-stadii-diabeticheskoi-nef

18. Wiseman AC, Huang E, Kamgar M, Bunnapradist S. The impact of pre-transplant dialysis on simultaneous pancreas–kidney versus living donor kidney transplant outcomes. Nephrol Dial Transplant. 2013;28(4):1047-1058. doi: https://doi.org/10.1093/ndt/gfs582

19. Zeier M, Ritz E. Preparation of the dialysis patient for transplantation. Nephrol Dial Transplant. 2002;17(4):552-556. doi: https://doi.org/10.1093/ndt/17.4.552

20. Chadban SJ, Ahn C, Axelrod DA, et al. KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation. 2020;104:S11-S103. doi: https://doi.org/10.1097/TP.0000000000003136

21. Federal Law of Russian Federation №4180-1 of 21 December 1992 «O transplantatsii organov I (ili) tkaney cheloveka (In Russ.). Доступно по: https://normativ.kontur.ru/document?moduleId=1&documentId=98490. Ссылка активна на 03.09.2020.

22. Asao K, Sarti C, Forsen T, et al. Long-Term Mortality in Nationwide Cohorts of Childhood-Onset Type 1 Diabetes in Japan and Finland. Diabetes Care. 2003;26(7):2037-2042. doi: https://doi.org/10.2337/diacare.26.7.2037

23. Groop PH, Thomas M, Feodoroff M, et al. Excess mortality in patients with type 1 diabetes without albuminuriadseparating the contribution of early and late risks. Diabetes Care. 2018. doi: https://doi.org/10.2337/dc17-1618

24. Groop P-H, Thomas MC, Moran JL, et al. The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes. Diabetes. 2009;58(7):1651-1658. doi: https://doi.org/10.2337/db08-1543

25. Cheung AK, Sarnak MJ, Yan G, et al. Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study. Kidney Int. 2004;65(6):2380-2389. doi: https://doi.org/10.1111/j.1523-1755.2004.00657.x

26. Rostand SG, Kirk KA, Rutsky EA. Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int. 1984;25(4):653-659. doi: https://doi.org/10.1038/ki.1984.70

27. Joki N, Hase H, Nakamura R, Yamaguchi T. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant. 1997;12(4):718-723. doi: https://doi.org/10.1093/ndt/12.4.718

28. Pinilla-Echeverri N, Moreno-Reig AL, Romera-Segorbe AM, et al. Prognostic factors of coronary heart disease in asymptomatic diabetics for inclusion on the kidney transplant waiting list. Screening with coronary angiography. Nefrologia. 2012;32(4):502-507. doi: https://doi.org/10.3265/Nefrologia.pre2012.Apr.11355

29. Snell-Bergeon JK, Hokanson JE, Jensen L, et al. Progression of coronary artery calcification in type 1 diabetes. Diabetes Care. 2003;26(10):2923-2928. doi: https://doi.org/10.2337/diacare.26.10.2923

30. Keshawarz A, Pyle L, Alman A, et al. Type 1 diabetes accelerates progression of coronary artery calcium over the menopausal transition: The CACTI Study. Diabetes Care. 2019;42(12):2315-2321. doi: https://doi.org/10.2337/dc19-1126

31. Orchard TJ, Kretowski A, Costacou T, Nesto RWE. Type 1 diabetes and coronary artery disease. Diabetes care. 2006;29(11):2528-2538. doi: https://doi.org/10.2337/dc06-1161

32. Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int. 1999;56(1):324-332. doi: https://doi.org/10.1046/j.1523-1755.1999.00540.x

33. House AA, Wanner C, Sarnak MJ, et al. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;95(6):1304-1317. doi: https://doi.org/10.1016/j.kint.2019.02.022

34. Kuo IY, Chapman A. Intracranial Aneurysms in ADPKD. Clin J Am Soc Nephrol. 2019;14(8):1119-1121. doi: https://doi.org/10.2215/CJN.07570719

35. Zander, Heinke, Reindel, et al. Periphere arterielle Verschlusskrankheit bei Diabetes mellitus Typ 1 und Typ 2: Unterscheiden sich die Risikofaktoren? Vasa. 2002;31(4):249-254. doi: https://doi.org/10.1024/0301-1526.31.4.249

36. Garimella PS, Hart PD, O’Hare A, et al. Peripheral Artery Disease and CKD: A Focus on Peripheral Artery Disease as a Critical Component of CKD Care. Am J Kidney Dis. 2012;60(4):641-654. doi: https://doi.org/10.1053/j.ajkd.2012.02.340

37. Stock PG, Barin B, Murphy B, et al. Outcomes of Kidney Transplantation in HIV-Infected Recipients. N Engl J Med. 2010;363(21):2004-2014. doi: https://doi.org/10.1056/NEJMoa1001197

38. Fabrizi F, Messa P, Martin P. Hepatitis B Virus Infection and the Dialysis Patient. Semin Dial. 2008;21(5):440-446. doi: https://doi.org/10.1111/j.1525-139X.2008.00437.x

39. Caragea C, Mihailovici AR, Streba CT, et al. Hepatitis C infection in hemodialysis patients. Curr Health Sci J. 2018;44(2):107-112. doi: https://doi.org/10.12865/CHSJ.44.02.02

40. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm. Rep. 2001;50:1-43. 0Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5005a1.htm

41. Finelli L, Miller JT, Tokars JI, et al. KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int Suppl. 2018;8(3):91-165. doi: https://doi.org/10.1016/j.kisu.2018.06.001

42. Pipili CL, Papatheodoridis GV, Cholongitas E.C. Treatment of hepatitis B in patients with chronic kidney disease. Kidney Intern. 2013;84:880-885. doi: https://doi.org/10.1038/ki.2013.249

43. Taborelli M, Toffolutti F, Del Zotto S, et al. Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy. BMC Nephrol. 2019;20(1):107. doi: https://doi.org/10.1186/s12882-019-1283-4

44. Penn I. The effect of immunosuppression on pre‐existing cancers. Transplantation. 1993;55(4):742-747. doi: https://doi.org/10.1097/00007890-199304000-00011

45. Molnar MZ, Huang E, Hoshino J, et al. Association of pretransplant glycemic controlwith posttransplant outcomes in diabetic kidney transplant recipients. Diabetes Care. 2011. doi: https://doi.org/10.2337/dc11-0906

46. Kim YC, Shin N, Lee S, et al. Effect of post-transplant glycemic control on long-term clinical outcomes in kidney transplant recipients with diabetic nephropathy: A multicenter cohort study in Korea. PLoS One. 2018;13(4):e0195566. doi: https://doi.org/10.1371/journal.pone.0195566

47. Glazunova AM. Dinamika metabolicheskih, gormonal’nyh i gemodinamicheskih faktorov u bol’nyh SD1 posle transplantazii pochki i sochetannoi transplantazii podzheludochnoi zhelezy i pochki. [dissertation] Moskva. (In Russ.). Доступно по: https://www.endocrincentr.ru/sites/default/files/specialists/science/dissertation/disser_glazunova2.pdf

48. Ramirez S, Maaske J, Kim Y, et al. The Association Between Glycemic Control and Clinical Outcomes After Kidney Transplantation. Endocr Pract. 2014;20(9):894-900. doi: https://doi.org/10.4158/EP13463.OR

49. Nakao T, Inaba M, Abe M, et al. Best Practice for Diabetic Patients on Hemodialysis 2012. Ther Apher Dial. 2015. doi: https://doi.org/10.1111/1744-9987.12299

50. Bedi R, Chowdhury T.A., El-Sherbini N. et al. JBDS-IP Management of adults with diabetes on the haemodialysis unit. 2016 Apr.

51. Abe M, Kaizu K, Matsumoto K. Evaluation of the Hemodialysis-induced changes in plasma glucose and insulin concentrations in diabetic patients: Comparison between the hemodialysis and non-hemodialysis days. Ther Apher Dial. 2007;11:288-295. doi: https://doi.org/10.1111/j.1744-9987.2007.00492.x

52. Jamaludin UK, Docherty PD, Geoffrey Chase J, Shaw GM. Impact of Haemodialysis on Insulin Kinetics of Acute Kidney Injury Patients in Critical Care. J Med Biol Eng. 2015;35(1):125-133. doi: https://doi.org/10.1007/s40846-015-0015-x

53. Rhee CM, Leung AM, Kovesdy CP, Lynch KE, Brent GA, Kalantar-Zadeh K. Updates on the Management of Diabetes in Dialysis Patients. Semin Dial. 2014;27(2):135-145. doi: https://doi.org/10.1111/sdi.12198

54. Tzamaloukas AH. Interpreting glycosylated hemoglobin in diabetic patients on peritoneal dialysis. Advances in Peritoneal Dialysis. 1996;12:171-175.

55. Sinha N, Mishra TK, Singh T, Gupta N. Effect of Iron Deficiency Anemia on Hemoglobin A1c Levels. Ann Lab Med. 2012;32(1):17-22. doi: https://doi.org/10.3343/alm.2012.32.1.17

56. Sharif A, Baboolal K. Diagnostic Application of the A 1c Assay in Renal Disease. J Am Soc Nephrol. 2010;21(3):383-385. doi: https://doi.org/10.1681/ASN.2010010031

57. Park J, Lertdumrongluk P, Molnar MZ, et al. Glycemic Control in Diabetic Dialysis Patients and the Burnt-Out Diabetes Phenomenon. Curr Diab Rep. 2012;12(4):432-439. doi: https://doi.org/10.1007/s11892-012-0286-3

58. Ramirez SPB, McCullough KP, Thumma JR, et al. Hemoglobin A1c Levels and Mortality in the Diabetic Hemodialysis Population: Findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Diabetes Care. 2012;35(12):2527-2532. doi: https://doi.org/10.2337/dc12-0573

59. Hoshino J, Larkina M, Karaboyas A, et al. Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients. Kidney Int. 2017;92(2):497-503. doi: https://doi.org/10.1016/j.kint.2017.02.008

60. Ricks J, Molnar MZ, Kovesdy CP, et al. Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes: A 6-Year Cohort Study. Diabetes. 2012;61(3):708-715. doi: https://doi.org/10.2337/db11-1015

61. Ricks J, Molnar MZ, Kovesdy CP, et al. Introduction: Standards of Medical Care in Diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S1-S2. doi: https://doi.org/10.2337/dc18-Sint01

62. Standards of specialized diabetes care. 9th edition (revised). Ed. by Dedov II, Shestakova MV, Mayorov AY. Moscow: Ministry of healthcare of the Russian Federation, 2019 (In Russ.).

63. KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Am J Transplant. Special Issue. 2009;9:S1-S155. doi: https://doi.org/10.1111/j.1600-6143.2009.02834.x

64. Moen MF, Zhan M, Hsu VD, et al. Frequency of Hypoglycemia and Its Significance in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2009;4(6):1121-1127. doi: https://doi.org/10.2215/CJN.00800209

65. Luo C, Constantino IMI, McGill MJ, et al. High rate of asymptomatic hypoglycemia in insulin-treated diabetes with severe chronic kidney disease: Utility of flash interstitial glucose monitoring. Diabetes Manag. 2018;8(5):128-136.

66. Javherani R, Purandare V, Bhatt A, et al. Flash glucose monitoring in subjects with diabetes on hemodialysis: A pilot study. Indian J Endocrinol Metab. 2018;22(6):848. doi: https://doi.org/10.4103/ijem.IJEM_520_18.

67. Pérez-Sáez M, Pascual J. Kidney Transplantation in the Diabetic Patient. J Clin Med. 2015;4(6):1269-1280. doi: https://doi.org/10.3390/jcm4061269

68. Sood A, Abdullah NM, Abdollah F, et al. Rates of Kidney Transplantation From Living and Deceased Donors for Blacks and Whites in the United States, 1998 to 2011. JAMA Intern Med. 2015;175(10):1716. doi: https://doi.org/10.1001/jamainternmed.2015.4530

69. Медвестник. Портал российского врача [интернет]. Доступно по: https://medvestnik.ru/content/news/V-Rossii-uvelichilos-kolichestvo-transplantacii-pochki.html. Ссылка активна на 21.12.2020.